Intuitive Surgical (ISRG) shares surged 5.04% during Monday's intraday trading session, as the stock rebounded from a recent post-earnings selloff with support from a maintained Buy rating and a new celebrity partnership announcement.

The upward move came after Rothschild & Co Redburn maintained its Buy rating on the stock, even as it lowered its price target to $540 from $615. The revised target still implies roughly 53% upside from current levels, providing a vote of confidence for the oversold stock. Separately, Intuitive announced a collaboration with Deion "Coach Prime" Sanders aimed at raising patient awareness of surgical options, including robotic-assisted surgery with da Vinci systems. The partnership leverages Sanders' public influence and personal experience with robotic surgery to promote understanding of modern surgical choices, signaling an active commercial marketing push by the company.

The stock had previously plunged over 11% following its Q2 earnings report on July 17. While adjusted EPS of $2.80 beat consensus by 12% and revenue of $2.89 billion also exceeded expectations, management maintained its full-year da Vinci procedure growth outlook of 13.5% to 15.5% without raising guidance, disappointing investors who had hoped for an upward revision. Multiple Wall Street firms subsequently cut price targets, though the majority maintain overweight or outperform ratings, with a consensus mean target near $492.